Search Results - "Visani, G."

Engine Mass Flow Estimation through Neural Network Modeling in Semi-Transient Conditions: A New Calibration Approach by Savioli, T., Pampanini, M., Visani, G., Esposito, L., Rinaldini, C. A.

“…Nowadays, engine experimental research represents a very expensive field within the automotive industry, but it remains fundamental for engine and vehicle…”
Get full text

Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT by Visani, G, Guiducci, B, Giardini, C, Loscocco, F, Ricciardi, T, Isidori, A

“…Cy 200mg/kg MUD…”
Get full text

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines by Santini, V, Alessandrino, P.E, Angelucci, E, Barosi, G, Billio, A, Di Maio, M, Finelli, C, Locatelli, F, Marchetti, M, Morra, E, Musto, P, Visani, G, Tura, S

“…Abstract Since 2002, date of publication of the previous Italian Society of Haematology (SIE) practice guidelines for management of myelodysplastic syndromes…”
Get full text

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients by Pagano, L., Valentini, C.G., De Stefano, V., Venditti, A., Visani, G., Petrucci, M.T., Candoni, A., Specchia, G., Visco, C., Pogliani, E.M., Ferrara, F., Galieni, P., Gozzetti, A., Fianchi, L., De Muro, M., Leone, G., Musto, P., Pulsoni, A.

“…Epidemiological and clinical information on primary plasma cell leukemia (pPCL) are rarely reported. The aims are to evaluate the clinical features, prognostic…”
Get full text

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients by Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D'Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele

“…The introduction and the extended clinical use of nilotinib in the first-line treatment of chronic myeloid leukemia have been based on company-sponsored…”
Get full text

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia by Visani, G, Manti, A, Valentini, L, Canonico, B, Loscocco, F, Isidori, A, Gabucci, E, Gobbi, P, Montanari, S, Rocchi, M, Papa, S, Gatti, A.M

“…Highlights • Increase in AML incidence suggest a possible environmental etiology. • PM-derived nanoparticles are linked to blood components in AML patients. •…”
Get full text

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) by Patriarca, Francesca, Bacigalupo, Andrea, Sperotto, Alessandra, Isola, Miriam, Soldano, Franca, Bruno, Barbara, van Lint, Maria Teresa, Iori, Anna Paola, Santarone, Stella, Porretto, Ferdinando, Pioltelli, Pietro, Visani, Giuseppe, Iacopino, Pasquale, Fanin, Renato, Bosi, Alberto, on behalf of GITMO

“…1 Division of Hematology and Cellular Therapies Unit ‘Carlo Melzi’, Dept. of Morphological and Medical Research, University of Udine 2 II Hematology Division,…”
Get full text

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine by Visani, G, Loscocco, F, Ruzzo, A, Galimberti, S, Graziano, F, Voso, M T, Giacomini, E, Finelli, C, Ciabatti, E, Fabiani, E, Barulli, S, Volpe, A, Magro, D, Piccaluga, P, Fuligni, F, Vignetti, M, Fazi, P, Piciocchi, A, Gabucci, E, Rocchi, M, Magnani, M, Isidori, A

“…We evaluated the impact of genomic polymorphisms in folate-metabolizing, DNA synthesis and DNA repair enzymes on the clinical outcome of 108 patients with…”
Get full text

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients by Visani, G, Ferrara, F, Di Raimondo, F, Loscocco, F, Sparaventi, G, Paolini, S, Fuligni, F, Gazzola, A, Rossi, M, Laginestra, M A, Caraci, M R, Riccardi, C, Rocchi, M, Visani, A, Pileri, S A, Piccaluga, P P, Isidori, A

Get full text

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL by Tiacci, E., De Carolis, L., Simonetti, E., Zaja, F., Capponi, M., Ambrosetti, A., Lucia, E., Antolino, A., Pulsoni, A., Ferrari, S., Zinzani, P., Rigacci, L., Gaidano, G., Della Seta, R., Frattarelli, N., Falcucci, P., Visani, G., Foà, R., Falini, B.

Get full text

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia by Visani, G, Piccaluga, P, Malagola, M, Isidori, A

Get full text

98 CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY by Finelli, C, Clissa, C, Follo, M.Y, Stanzani, M, Parisi, S, Avanzini, P, Bosi, C, Castagnari, B, Candoni, A, Crugnola, M, Giannini, M.B, Gobbi, M, Leonardi, G, Rigolin, G.M, Russo, D, Tosi, P, Visani, G, Cocco, L, Cavo, M

Get full text

251 TS, MTHFR AND XRCC1 GENETIC VARIANTS INFLUENCE THE OUTCOME OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK by Visani, G, Loscocco, F, Ruzzo, A, Voso, M, Fabiani, E, Finelli, C, Graziano, F, Barulli, S, Volpe, A, Magro, D, Piccaluga, P, Fuligni, F, Gabucci, E, Giacomini, E, Vignetti, M, Fazi, P, Piciocchi, A, Rocchi, M, Magnani, M, Isidori, A

Get full text

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study by PICCALUGA, P. P, VISANI, G, BACCARANI, M, TURA, S, PILERI, S. A, ASCANI, S, GRAFONE, T, ISIDORI, A, MALAGOLA, M, FINELLI, C, MARTINELLI, G, RICCI, P

“…Increased neoangiogenesis has been reported in myelofibrosis with myeloid metaplasia (MMM). Thus we studied the effects of thalidomide, an antiangiogenic drug,…”
Get full text

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate by LAURIA, F, RASPADORI, D, RONDELLI, D, VENTURA, M. A, FIACCHINI, M, VISANI, G, FORCONI, F, TURA, S

“…Flow cytometric expression of bcl-2 protein was analyzed in 90 newly diagnosed acute myeloblastic leukemia (AML) patients using an anti-bcl-2 monoclonal…”
Get full text

Karyotype in acute myeloblastic leukemia : Prognostic significance for bone marrow transplantation in first remission : A european group for blood and marrow transplantation study by FERRANT, A, LABOPIN, M, LÖWENBERG, B, GORIN, N. C, FRASSONI, F, PRENTICE, H. G, CAHN, J. Y, BLAISE, D, REIFFERS, J, VISANI, G, SANZ, M. A, BOOGAERTS, M. A

Get full text

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients by VISANI, G, BERNASCONI, P, FALZETTI, D, FANIN, R, GOBBI, M, ISIDORI, A, LEONI, F, LISO, V, MALAGOLA, M, MARTINELLI, G, MECUCCI, C, PICCALUGA, P. P, BONI, M, PETTI, M. C, RONDELLI, R, RUSSO, D, SESSAREGO, M, SPECCHIA, G, TESTONI, N, TORELLI, G, MANDELLI, F, TURA, S, CASTOLDI, G. L, CIOLLI, S, CLAVIO, M, COX, M. C, CUNEO, A, DEL POETA, G, DINI, D

“…We studied the impact of cytogenetics and kind of induction/consolidation therapy on 848 adult acute myeloid leukemia (AML) patients (age 15-83). The patients…”
Get full text

Long-term molecular complete remission with IFN-α in Ph+ adult acute lymphoid leukemia patients by Piccaluga, P P, Martinelli, G, Isidori, A, Malagola, M, Rondoni, M, Paolini, S, Amabile, M, Iacobucci, I, Baccarani, M, Visani, G

Get full text

P.1.149: NBI IN THE DIAGNOSIS OF GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE: A FEASIBLE TOOL FOR DETECTING MUCOSA AND VASCULAR ABNORMALITIES AT THE TIME OF ENDOSCOPY by De Luca, L, Rogheto, M, Giardini, C, Fabi, M.T, Cioccolini, P, Bianchi, M.L, Mortilla, M.G, Lucesole, M, De Nictolis, M, Visani, G, Baroncini, D

Get full text

Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature by Piccaluga, P P, Ascani, S, Agostinelli, C, Paolini, S, Laterza, C, Papayannidis, C, Martinelli, G, Visani, G, Baccarani, M, Pileri, S A

Get full text